Skip to main content
Donate
Login
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Search
Donate
Login
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2024
Research & Education
Research & Education
Scientific Projects
Scientific Projects
IASLC Staging Project: Lung Cancer, Thymic Tumors, and Mesothelioma
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Past IASLC Scientific Projects
Lung Cancer 360
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Early-Career Opportunities
Early-Career Opportunities
IASLC Academy
Publications, Resources & Guidelines
News
News
ILCN
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
IASLC Partnerships
Patient Advocacy
Patient Advocacy
STARS
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 1333 - 1344 items out of 1999 results
ILCN article
See WCLC 2022’s Top-Rated Abstracts During Monday’s Presidential Symposium
ILCN article
mRNA Cancer Vaccines Show Early Clinical Promise
ILCN article
Researchers Present Significant Trial Results During WCLC 2022
Podcast
Lung Cancer Research Trends in France with Dr. Benjamin Besse at IASLC 2019 WCLC
Press release
Phase II Study of Durvalumab Plus Concurrent Radiotherapy in Unresectable Locally Advanced NSCLC: DOLPHIN Study
Press release
Consolidation Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation for Patients with Unresectable Stage III NSCLC
Press release
United Kingdom-Based Smoking Cessation Program Reports That 30 Percent of Support in a Lung Cancer Screening Program: The Yorkshire Enhanced Stop Smoking Study (YESS)
Press release
Overall Survival Interim Analysis of a Phase III Study of Atezolizumab vs Best Supportive Care in Resected NSCLC
Press release
International Association for the Study of Lung Cancer Hosts World Conference on Lung Cancer Presidential Symposium Press Briefing on Monday, August 8, 2022
Press release
Sub-Lobar Surgery for Peripheral Non-Small Cell Lung Cancer Non-Inferior to Lobectomy
Press release
NADIM II Trial Provides Further Support for Neoadjuvant Chemoimmunotherapy for Patients with Resectable Non-Small Cell Lung Cancer
ILCN article
Mini Oral Session Examines Research Surrounding Patient Advocacy Issues
Pagination
First
First page
‹
Previous page
…
108
109
110
111
112
113
114
115
116
…
›
Next page
Last
Last page